Grace Therapeutics, Inc. Non Peo Neo Avg Comp Actually Paid Amt
Grace Therapeutics, Inc. (GRCE) reported Non Peo Neo Avg Comp Actually Paid Amt of $558.60 thousand for the 12-month period ending 2026-03-31, per its DEF 14A filed 2026-07-28.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-07-28
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2026-03-31 | $558.60K DEF 14A · filed 2026-07-28 |
| 2025-03-31 | $371.18K DEF 14A · filed 2026-07-28 |
| 2024-03-31 | $720.22K DEF 14A · filed 2026-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |